Literature DB >> 18287963

Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles.

Nina Holland1, Jing Dong, Elizabeth Garnett, Nishat Shaikh, Karen Huen, Paul Harmatz, Anthony Olive, Harland S Winter, Benjamin D Gold, Stanley A Cohen, Robert N Baldassano, Barbara S Kirschner, Melvin B Heyman.   

Abstract

Abnormal cytokine production by T-helper 1 (Th1)/T-helper 2 (Th2) lymphocytes has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Few studies have examined Th1/Th2 cytokine status in pediatric IBD patients, and results have been inconsistent. We used flow cytometric detection of intracellular IFN-gamma/IL-4 cytokine production to investigate CD4+, Th1, and Th2 cells in the peripheral blood of children with untreated, newly diagnosed Crohn's disease (CD) (n = 23) and matched healthy controls (n = 49). Th1 cytokine levels were lower in CD patients compared with controls (p = 0.006) and strongly correlated with levels of albumin and hematocrit (r = 0.51, p = 0.007 and r = 0.35, p = 0.052, respectively). An age-dependent increase in Th1 cells was observed (p < 0.0005); however, no correlation was found between age, clinical end points, %CD4+, or Th2 cell numbers. In conclusion, the Th1 cytokine levels in blood are lower in early onset CD patients than in healthy children and are directly associated with disease-related clinical parameters. In future studies of pediatric IBD patients, it will be critical to consider the effect of age and disease progression on cytokine status in intestinal mucosa and peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287963      PMCID: PMC3252046          DOI: 10.1203/PDR.0b013e318163a897

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  38 in total

1.  Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.

Authors:  O H Nielsen; I Kirman; N Rüdiger; J Hendel; B Vainer
Journal:  Scand J Gastroenterol       Date:  2003-02       Impact factor: 2.423

2.  Pediatric inflammatory bowel disease: what children can teach adults.

Authors:  Elizabeth Hait; Liz Hait; Athos Bousvaros; Richard Grand
Journal:  Inflamm Bowel Dis       Date:  2005-06       Impact factor: 5.325

Review 3.  Cytokines and inflammatory bowel disease.

Authors:  G Radford-Smith; D P Jewell
Journal:  Baillieres Clin Gastroenterol       Date:  1996-03

Review 4.  Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.

Authors:  A Nassif; W E Longo; J E Mazuski; A M Vernava; D L Kaminski
Journal:  Dis Colon Rectum       Date:  1996-02       Impact factor: 4.585

5.  Ontogeny of T-helper 1 and T-helper 2 cytokine production in childhood.

Authors:  J M Smart; A S Kemp
Journal:  Pediatr Allergy Immunol       Date:  2001-08       Impact factor: 6.377

6.  Peripheral blood intracellular cytokine analysis in children newly diagnosed with inflammatory bowel disease.

Authors:  David R Mack; Susan Beedle; Jame Warren; Jack Davis; Thomas Gross
Journal:  Pediatr Res       Date:  2002-03       Impact factor: 3.756

7.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

8.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

9.  Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.

Authors:  R Karttunnen; E J Breese; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

Review 10.  Cytokines and other immunological biomarkers in children's environmental health studies.

Authors:  Paurene Duramad; Ira B Tager; Nina T Holland
Journal:  Toxicol Lett       Date:  2007-05-25       Impact factor: 4.372

View more
  7 in total

1.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

2.  Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.

Authors:  Rivkah Gonsky; Richard L Deem; Carol J Landers; Carrie A Derkowski; Dror Berel; Dermot P B McGovern; Stephan R Targan
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

3.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

4.  Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.

Authors:  Olga Y Korolkova; Jeremy N Myers; Samuel T Pellom; Li Wang; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2015-05-06

Review 5.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

Review 6.  Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Authors:  Eirini Giannoudaki; Siobhan Gargan; Seamus Hussey; Aideen Long; Patrick T Walsh
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

7.  Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.

Authors:  Bianca Mendes Souza; Tatiane Melo Preisser; Vanessa Bastos Pereira; Meritxell Zurita-Turk; Camila Prósperi de Castro; Vanessa Pecini da Cunha; Rafael Pires de Oliveira; Ana Cristina Gomes-Santos; Ana Maria Caetano de Faria; Denise Carmona Cara Machado; Jean-Marc Chatel; Vasco Ariston de Carvalho Azevedo; Philippe Langella; Anderson Miyoshi
Journal:  Microb Cell Fact       Date:  2016-08-30       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.